Furthermore, this study calculated risk estimates using a less robust method, leading to an uncertain conclusion.[8–10] Therefore, we included newly published studies, adopted a more accurate statistical method, and conducted an updated meta-analysis, to further investigate the significance of HER-2 overexpression on the prognosis of osteosarcoma. The gene discussed is ERBB2; the disease is osteosarcoma.